MedPath

Test of motivational treatments to reduce alcohol use.

Not Applicable
Active, not recruiting
Conditions
Alcohol Use Disorder
Mental Health - Addiction
Registration Number
ACTRN12616000480482
Lead Sponsor
Professor David J. Kavanagh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
480
Inclusion Criteria

Participants will be aged 18 years or over and report consuming >40 gm of ethanol (4 standard drinks)/day on average in the past 4 weeks. They will fulfil criteria for current DSM-5 Alcohol Use Disorder and deny intravenous drug use or >twice-weekly cannabis use in the last month. They will not be in concurrent psychological treatment for substance use, and if on naltrexone or acamprosate, will have been on a stable dose for >4 weeks. If highly dependent on alcohol or drinking >700 gm ethanol/week, they will obtain a medical assessment and agree to any medical treatment that is needed, including a medically supervised detoxification if required. They must have access to a smartphone to be able to use the treatment app.

Exclusion Criteria

Exclusion criteria include insufficient English to read or converse without translation, pregnancy or high dependence on medical care, unmodified hearing impairment, significant cognitive deficit, history of >3 days of psychosis, and acute current suicidality.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Average weekly alcohol consumption over the past 4 weeks in 10 gm ethanol units (‘standard drinks’) assessed using the Timeline Followback (TLFB).[3, 6 and 12 months post-Baseline.<br><br>];Cost-effectiveness for quality-adjusted life years measured using the Assessment of Quality of Life - 8 Dimensions (AQoL-8D).[12 months post-Baseline.]
Secondary Outcome Measures
NameTimeMethod
Average drinks/drinking day over the past 4 weeks assessed using the Timeline Followback (TLFB).<br>[3, 6 and 12 months post-Baseline.];Average weekly days abstinent in the past 4 weeks assessed using the Timeline Followback (TLFB).[3, 6 and 12 months post-Baseline.];Motivation to control drinking assessed using the Motivational Thought Frequency Scale (MTF).[1 week, 3 months, 6 months and 12 months post-Baseline.];Craving for alcohol assessed using the Craving Experience Questionnaire (CEQ).[1 week, 3 months, 6 months, and 12 months post-Baseline.];Health related quality of life assessed using the Assessment of Quality of Life - 8 Dimensions (AQoL-8D).[3, 6, and 12 months post-Baseline.];Psychological distress assessed using the Kessler 10 (K10).[3, 6, and 12 months post-Baseline.];Relative cost-effectiveness assessed using health service utilisation questions developed for this trial.[3, 6 and 12 months post-Baseline.]
© Copyright 2025. All Rights Reserved by MedPath